ARCHIVES

Also in this 8-page issue: M.D. Anderson Cancer Center wins ninth SPORE grant, this time for melanoma research.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

April 30, 2010

October issue of Business & Regulatory Report included.

November 5, 2004

House Medicare Reform Bill Takes A smaller Bite In Drug Reimbursement

June 20, 1997

Lenalidomide, An Altered Thalidomide, Shows Promise

November 24, 2006

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

January 28, 2011